Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Vos

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Sexually Transmitted Infections|May 19, 2016
Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS studyC J Alberts, R A Vos, H Borgdorff, et al.
The Journal of Infection|October 25, 2024
Exposure, infection and disease with the tick-borne pathogen Borrelia miyamotoi in the Netherlands and Sweden, 2007-2019Dieuwertje Hoornstra, Olga A Stukolova, Jacqueline A van Eck, et al.
Influenza and Other Respiratory Viruses|August 25, 2023
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the NetherlandsPieter T de Boer, Jan van de Kassteele, Eric R A Vos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2021
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective StudyGerco den Hartog, Eric R A Vos, Lotus L van den Hoogen, et al.
Mucosal Immunology|March 29, 2024
Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the NetherlandsMarije K Verheul, Joanna Kaczorowska, Marloes I Hofstee, et al.
Scientific Reports|April 9, 2022
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kineticsLotus L van den Hoogen, Marije K Verheul, Eric R A Vos, et al.
Vaccine|March 15, 2022
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?Lotus L van den Hoogen, Gaby Smits, Cheyenne C E van Hagen, et al.
Vaccine: X|October 24, 2024
A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvementsA J M Pluijmaekers, A Steens, H Houweling, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Sexually Transmitted Infections|May 19, 2016
Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS studyC J Alberts, R A Vos, H Borgdorff, et al.
The Journal of Infection|October 25, 2024
Exposure, infection and disease with the tick-borne pathogen Borrelia miyamotoi in the Netherlands and Sweden, 2007-2019Dieuwertje Hoornstra, Olga A Stukolova, Jacqueline A van Eck, et al.
Influenza and Other Respiratory Viruses|August 25, 2023
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the NetherlandsPieter T de Boer, Jan van de Kassteele, Eric R A Vos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2021
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective StudyGerco den Hartog, Eric R A Vos, Lotus L van den Hoogen, et al.
Mucosal Immunology|March 29, 2024
Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the NetherlandsMarije K Verheul, Joanna Kaczorowska, Marloes I Hofstee, et al.
Scientific Reports|April 9, 2022
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kineticsLotus L van den Hoogen, Marije K Verheul, Eric R A Vos, et al.
Vaccine|March 15, 2022
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?Lotus L van den Hoogen, Gaby Smits, Cheyenne C E van Hagen, et al.
Vaccine: X|October 24, 2024
A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvementsA J M Pluijmaekers, A Steens, H Houweling, et al.
Pageof 3